Focus Partners Advisor Solutions’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Focus Partners Advisor Solutions's AMGN Position: Q2 2026 in Review
Focus Partners Advisor Solutions increased its Amgen (AMGN) stake by 19% in Q2 2026, buying an estimated $363K and bringing the position to 6,527 shares worth $2.36M. The position accounts for 0.02% of the portfolio, ranked #334.
Focus Partners Advisor Solutions first reported a position in AMGN in Q1 2022 and has held it in 18 quarters since. The position peaked at $3.36M in Q4 2025. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Focus Partners Advisor Solutions held 6,527 shares of Amgen worth $2.36M as of Q2 2026.
- Focus Partners Advisor Solutions bought 1,060 Amgen shares in Q2 2026, an estimated $363K.
- Amgen made up 0.02% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #334 holding.
- Focus Partners Advisor Solutions first reported a position in Amgen in Q1 2022 and has held it in 18 quarters since.
- Focus Partners Advisor Solutions's Amgen position peaked at $3.36M in Q4 2025.
- 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.